Product Description
Leading Justice is a full-service marketing company working with law firms on a cash buy basis to sign up fully-qualified, fraud-free Essure birth control cases. Here at Leading Justice, we can custom-tailor your firm’s Essure advertising needs and help you sign up cases via internal cash buys. Our clients only pay an agency fee to cover the cost of Essure advertising, plus a fee for every case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all of our contacts, meaning any data we generate that isn’t eligible for the target campaign is reviewed to find out if it qualifies for another type of claim. By using advanced approaches to target contacts specifically related to Essure and side effects like device migration and perforation of internal organs, Leading Justice will increase your firm’s Essure case load. If you are interested in helping victims of alleged Essure complications, our extensive consumer reach and direct advertising strategies at Leading Justice give you the competitive edge and confidence you need to allocate your full budget, with the knowledge that your money is being used in the best way possible.
Each and every law firm we work with at Leading Justice plays an integral role in determining how we categorize claims as qualified or not. While our extensive experience working with plaintiff law firms allows us to recognize a great case when we see one, we will customize our Essure case intake specifications to the exact criteria you are seeking. So, if your firm has specific Essure qualifying case criteria you would like us to use, we can train our intake specialists to apply the criteria to each email and phone call they receive. By getting rid of the middle man, Leading Justice offers clients an opportunity for internal cash buys of Essure data with no chance of fraud.
Essure Birth Control Litigation
Essure is a birth control device manufactured by Bayer Healthcare, and involves implanting small coils in the fallopian tubes to prevent pregnancy, by promoting the growth of scar tissue in and around the insert. Essure was introduced in the United States in 2002, and since that time, it has been marketed by Bayer as a safer, easier and cheaper means of permanent pregnancy prevention, compared to a traditional tubal ligation. However, the FDA recently announced that, since 2004, it has received close to 1,000 adverse event reports from women who received an Essure birth control implant, detailing devastating complications like device migration, colon perforation, implant failure, and other side effects, some of which required a hysterectomy to remove the device.
Although the Essure birth control system is less well-known than other forms of birth control, like Yaz and Yasmin, the alleged side effects are just as dangerous. The risk of Essure complications is so severe in fact, that famed consumer advocate Erin Brockovich has stepped forward in an effort to raise awareness about the potential for Essure birth control to cause serious and possibly even fatal side effects among women. According to Bayer Healthcare, roughly 750,000 women have already received an Essure birth control implant, and as more and more women across the country become aware of the risk of potentially life-threatening complications linked to the Essure birth control system, a growing number of complaints are expected to be brought against Bayer in the future.
